Seguimos Avanzando - Latino Youth Coping With Discrimination

November 26, 2024 updated by: Margarita Alegria, PhD, Massachusetts General Hospital

Latino Youth Coping With Discrimination: A Multi-Level Investigation in Micro- and Macro-Time

The overall objective of this study is to investigate mediators and moderators at multiple ecological (individual, family/peer and school/neighborhood levels) and time-scale (micro- and macro-time) levels in the link between discrimination-related stressors and mental health among 340 Mexican-origin youth.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The project's long-term goal is to improve the mental health of Mexican-origin youth by reducing the deleterious effects of racism, "othering," and negative neighborhood interactions. Community based collaboration will be used to recruit a sample of 340 Mexican-origin adolescents, mothers, and fathers in Indiana. The inclusion of fathers will be a valuable contribution to the literature, given the dearth of studies on Latinx fathers/stepfathers. A combination of annual surveys administered over three waves to parents and youth ("macro-time") and a 21-day daily diary ("micro-time") administered in wave 1 to youth is employed to assess important questions about how mediating and moderating processes unfold over time. Specific aims of the project include determination of within-person discrimination-related stressors that impact youth's mental health outcomes and the mechanisms of action at both micro- and macro- time levels; identification of protective factors that could help coping with discrimination related stressors and conditions under which they work; and elucidating youth, parent, and neighborhood risk factors that moderate the link between discrimination-related stressors and mental health outcomes in youth. This research is highly translational in that it will facilitate the development of more effective, culturally sensitive prevention and intervention strategies for Latinx youth and their families.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
886

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • United States
    • Indiana
      • South Bend, Indiana, United States, 46635
        • University of Notre Dame, William J. Shaw Center for Children and Families

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

  • Mexican descent adolescents between the ages of 12-15 years old (at enrollment)
  • Mexican-Origin caregivers over the age of 18

Description

Inclusion Criteria:

Adolescent Inclusion Criteria:

  • The adolescent has two eligible caregivers (as defined in the following criteria)
  • The adolescent resides with at least one of the two caregivers.
  • One of the caregivers is a parent or legal guardian who is eligible to give consent for the child's participation.

Caregiver Inclusion Criteria:

  • Biological Parents of Mexican origin
  • Legal guardians of Mexican origin
  • Step-parents of Mexican origin
  • A caregiver of Mexican origin identified by the parent/guardian who is 18 or older (e.g., grandparents, uncles/aunts, older siblings, godparents)

Exclusion Criteria:

  • A parent reports that the adolescent has a severe learning or developmental disability which would prevent understanding/survey response

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]
Time Frame: Time 0 (baseline)
Youth Depression, Total score 0-24, Higher scores are worse
Time 0 (baseline)
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]
Time Frame: Month 12
Youth Depression, Total score 0-24, Higher scores are worse
Month 12
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]
Time Frame: Month 24
Youth Depression, Total score 0-24, Higher scores are worse
Month 24
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)
Time Frame: Time 0 (baseline)
Youth Anxiety, Subscale Total score 0-18, Higher scores are worse
Time 0 (baseline)
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)
Time Frame: Month 12
Youth Anxiety, Subscale Total score 0-18, Higher scores are worse
Month 12
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)
Time Frame: Month 24
Youth Anxiety, Subscale Total score 0-18, Higher scores are worse
Month 24
Youth Self-Report for Ages 11-18 (YSR/11-18)
Time Frame: Time 0 (baseline)
Youth Psychological Symptoms
Time 0 (baseline)
Youth Self-Report for Ages 11-18 (YSR/11-18)
Time Frame: Month 12
Youth Psychological Symptoms
Month 12
Youth Self-Report for Ages 11-18 (YSR/11-18)
Time Frame: Month 24
Youth Psychological Symptoms
Month 24
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)
Time Frame: Time 0 (baseline)
Adaptive Functioning
Time 0 (baseline)
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)
Time Frame: Month 12
Adaptive Functioning
Month 12
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)
Time Frame: Month 24
Adaptive Functioning
Month 24
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Time 0 (baseline)
Sleep Duration and Quality; Total global score (for unadapted scale) 0-21
Time 0 (baseline)
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Month 12
Sleep Duration and Quality; Total global score (for unadapted scale) 0-21
Month 12
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Month 24
Sleep Duration and Quality; Total global score (for unadapted scale) 0-21
Month 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Massachusetts General Hospital

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Indiana University
University of Notre Dame
Fordham University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 9, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 11, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 11, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 9, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 4, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 6, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 29, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2020P001721

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings